RusnanoMedInvest: Funding, Team & Investors | Startup Intros

Loading organizations...

RusnanoMedInvest: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2017	Epic Sciences	$40.0M Series D	Jerry Xiao	Deerfield Management, Domain Associates, Altos Capital Partners, Frederic Pla, Pagoda Investment, Reach Tone Limited, Sabby Capital, VI Ventures
Jan 1, 2017	Binx Health	$35.0M Series D	—	Earlybird Venture Capital, EQT Life Sciences, HealthCap, OrbiMed, BB Biotech Ventures, dRx Capital, Johnson & Johnson Innovation, LSP, Technology Venture Partners, Wondfo Biotech
Aug 1, 2015	Syndax Pharmaceuticals	$80.0M Series C	Delos, Fidelity Management & Research Company	aMoon Fund, Domain Associates, InterWest, Osage University Partners, T1D Fund, Vivo Capital, Arrowpoint Partners, BioMed Ventures, Cormorant Asset Management, EcoR1 Capital, Forward Ventures, Greenwood Capital, Jennison Associates, MPM Capital, OrbiMed, Tavistock Group
Jun 8, 2015	Celtaxsys	$45.0M Grant / Series D	Nicole Vitullo	Cystic Fibrosis Foundation, Georgia Research Alliance, Gerry Brunk, Masters Capital Management, Maxim Gorbachev
Jan 1, 2015	Binx Health	$20.0M Series C	—	Earlybird Venture Capital, HealthCap, BB Biotech Ventures, Johnson & Johnson Innovation, LSP, Novartis, South West Ventures Fund
Sep 1, 2014	Clearside Biomedical	$16.0M Series B	—	Hatteras Venture Partners, Georgia Research Alliance, Mountain Group Partners, Santen Pharmaceutical
Aug 1, 2014	ALDEA Pharmaceuticals	$24.0M Series B	—	Canaan Partners, Omega Funds, Canaan Partners, Correlation Ventures, WuXi AppTec
Jul 1, 2014	Epic Sciences	$30.0M Series C	—	Deerfield Management, Domain Associates, Arcus Ventures, Pfizer, Roche
Feb 12, 2014	Miramar Labs	$10.0M Series D	—	Aisling Capital, Cross Creek Advisors, Domain Associates, Morgenthaler Ventures
Oct 3, 2013	NovaDigm Therapeutics	$14.0M Series B	Domain Associates, RusnanoMedInvest	—
Aug 1, 2013	Syndax Pharmaceuticals	$27.0M Series B	—	aMoon Fund, Domain Associates, InterWest, Osage University Partners, T1D Fund, Vivo Capital, Forward Ventures, MPM Capital
Jan 1, 2013	Marinus Pharmaceuticals	$21.0M Series C	—	Canaan Partners, Domain Associates, Canaan Partners, Foundation Medical Partners, Sofinnova Ventures
Dec 1, 2012	Regado Biosciences	$51.0M Series E	RusnanoMedInvest	Domain Associates, Aurora Funds, Baxter Ventures, Caxton Advantage, Quaker Partners
Jul 1, 2012	Ocunexus Therapeutics	$20.0M Series B	—	Domain Associates, Kleiner Perkins, Versant Ventures, BioPacificVentures, GBS Venture Partners